Details.
A purified preparation of antibodies pooled from thousands of healthy blood donors, offered as a standalone infusion therapy or as a complement to therapeutic plasma exchange for select patients. IVIG is administered only after a thorough medical evaluation. The treatment uses a standard peripheral IV, requires no central line or apheresis machine, and includes vital sign monitoring throughout. Patients leave the same day. Mild, transient effects such as headache or fatigue can occur and typically resolve within 24 hours. For longevity and post-infectious indications, treatment is often administered monthly or biweekly, with an individualized schedule based on the patient's clinical picture and response.